|
1TEN
STRUCTURE OF A FIBRONECTIN TYPE III DOMAIN FROM TENASCIN PHASED BY MAD ANALYSIS OF THE SELENOMETHIONYL PROTEIN
Deposited 1992-08-28
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
802–891(90 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.80 Å
|
|
2RB8
High resolution design of a protein loop
Deposited 2007-09-18
|
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
802–893(92 aa)
Fragment:unp residues 802-896
|
Mutation:M24F, P25K, S27L, Q28A, P29E, V30I, F33I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;3.8M sodium formate, 5% glycerol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 1.45 Å
R-free 0.196
|
|
6QNV
Fibrinogen-like globe domain of Human Tenascin-C
Deposited 2019-02-12
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1979–2196(218 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;Morpheus 0.09M NPS, 0.1M Buffer System 3 pH = 8.5, 50% v/v Precipitant Mix 1
|
Resolution 1.40 Å
R-free 0.182
|
|
8FN8
Crystal structure of the C-terminal Fg domain of TNC with the single FN domain of PTPRZ
Deposited 2022-12-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1975–2201(227 aa)
Fragment:Fg domain (UNP residues 1975-2201)
|
Not recorded
|
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;20% w/v PEG3350, 100 mM Tris-HCl, pH 8.0
|
Resolution 1.89 Å
R-free 0.205
|
|
8FNB
Crystal structure of the C-terminal Fg domain of human TNC with the mutations Y2140H and S2164H
Deposited 2022-12-27
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1975–2201(227 aa)
Fragment:Fg domain (UNP residues 1975-2201)
|
Mutation:Y2140H, S2164H
|
CA CALCIUM ION × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;200 mM lithium sulfate, 25% PEG1500, 50 mM Tris, pH 8.0
|
Resolution 1.80 Å
R-free 0.174
|
|
8FNB
Crystal structure of the C-terminal Fg domain of human TNC with the mutations Y2140H and S2164H
Deposited 2022-12-27
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1975–2201(227 aa)
Fragment:Fg domain (UNP residues 1975-2201)
|
Mutation:Y2140H, S2164H
|
CA CALCIUM ION × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;200 mM lithium sulfate, 25% PEG1500, 50 mM Tris, pH 8.0
|
Resolution 1.80 Å
R-free 0.174
|
|
9NIG
PB TCR in complex with HLA-DR4 presenting citrullinated Tenascin C peptide
Deposited 2025-02-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain P
1013–1024(12 aa)
Fragment:residues 1013-1024
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M Tris pH7.5, 0.3M NaCl, 0.05 M Glutamic acid, 0.05M Arginine, 20% PEG3350
|
Resolution 3.20 Å
R-free 0.260
|
|
9NIG
PB TCR in complex with HLA-DR4 presenting citrullinated Tenascin C peptide
Deposited 2025-02-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain G
1013–1024(12 aa)
Fragment:residues 1013-1024
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M Tris pH7.5, 0.3M NaCl, 0.05 M Glutamic acid, 0.05M Arginine, 20% PEG3350
|
Resolution 3.20 Å
R-free 0.260
|
|
9NIG
PB TCR in complex with HLA-DR4 presenting citrullinated Tenascin C peptide
Deposited 2025-02-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain L
1013–1024(12 aa)
Fragment:residues 1013-1024
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M Tris pH7.5, 0.3M NaCl, 0.05 M Glutamic acid, 0.05M Arginine, 20% PEG3350
|
Resolution 3.20 Å
R-free 0.260
|
|
9NIH
Crystal structure of HLA-DR4 presenting citrullinated Tenascin C peptide
Deposited 2025-02-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1013–1024(12 aa)
Fragment:residues 1013-1024
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;0.2 M NaCl, 0.1 M Bis Tris pH 5.5, 29% PEG3350
|
Resolution 2.40 Å
R-free 0.219
|
|
9R5Y
Crystal structure of the C-terminal domain of human TNC in complex with Adhiron 52
Deposited 2025-05-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1976–2193(218 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.4;291.15 K;10% w/v PEG 20 000, 20% v/v PEG MME 550, 0.02 M sodium formate, 0.02 M ammonium acetate,
0.02 M trisodium citrate, 0.02 M sodium potassium
l-tartrate, 0.02 M sodium oxamate, 0.1 M bicine/Trizma base pH 8.5
|
Resolution 1.40 Å
R-free 0.185
|
|
9R5Y
Crystal structure of the C-terminal domain of human TNC in complex with Adhiron 52
Deposited 2025-05-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
1976–2193(218 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.4;291.15 K;10% w/v PEG 20 000, 20% v/v PEG MME 550, 0.02 M sodium formate, 0.02 M ammonium acetate,
0.02 M trisodium citrate, 0.02 M sodium potassium
l-tartrate, 0.02 M sodium oxamate, 0.1 M bicine/Trizma base pH 8.5
|
Resolution 1.40 Å
R-free 0.185
|